NON RARE IN EUROPE: Lactase non-persistence in adulthood

Lactase non-persistence in adulthood, commonly known as adult-type lactose intolerance or lactase deficiency, is a very common condition in which the body gradually loses its ability to produce lactase — the enzyme needed to digest lactose, the main sugar found in milk and dairy products. Almost all humans produce plenty of lactase as infants, which allows them to digest breast milk. However, in most of the world's population, lactase production naturally decreases after weaning during childhood or adolescence. When undigested lactose reaches the large intestine, gut bacteria ferment it, producing gas and drawing water into the bowel. This leads to symptoms such as bloating, abdominal cramps, gas, diarrhea, and nausea after consuming dairy products. It is important to understand that lactase non-persistence is not a disease in the traditional sense — it is actually the ancestral, normal biological state for most humans. The ability to digest lactose into adulthood (called lactase persistence) is a relatively recent genetic adaptation that became common mainly in populations with a long history of dairy farming, such as those of Northern European descent. Management is straightforward and focuses on dietary adjustments. Most people can tolerate small amounts of dairy, especially fermented products like yogurt and aged cheeses, which contain less lactose. Lactase enzyme supplements taken before meals can help digest dairy. For those who avoid dairy entirely, calcium and vitamin D supplementation may be recommended to prevent nutritional deficiencies. The condition does not shorten lifespan or cause serious health complications.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Data is compiled from FDA regulatory filings and ClinicalTrials.gov, then processed through automated extraction; event classifications and dates may occasionally be misclassified. Verify against the linked FDA filing or trial record before clinical decisions. Updated periodically.

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

Bring these to your next appointment

• Q1.How much dairy can I safely consume without triggering symptoms?,Should I take a hydrogen breath test or genetic test to confirm the diagnosis?,Do I need calcium or vitamin D supplements if I reduce my dairy intake?,Are lactase enzyme supplements safe for long-term daily use?,Could my symptoms be caused by something other than lactose intolerance, such as a milk allergy or irritable bowel syndrome?,Are there specific foods I should watch out for that contain hidden lactose?,Should my children be tested for lactase non-persistence?

Common questions about NON RARE IN EUROPE: Lactase non-persistence in adulthood